NCT00455351View on ClinicalTrials.gov

Vorinostat and Palliative Radiotherapy

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

August 31, 2009

Conditions
Pelvic CancerRadiotherapy
Interventions
DRUG

Vorinostat

Increasing dosing, phase I

Trial Locations (1)

NO-0310

The Norwegian Radium Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT00455351 - Vorinostat and Palliative Radiotherapy | Biotech Hunter | Biotech Hunter